ATE373718T1 - 17867, eine menschliche aminopeptidase - Google Patents

17867, eine menschliche aminopeptidase

Info

Publication number
ATE373718T1
ATE373718T1 AT00945107T AT00945107T ATE373718T1 AT E373718 T1 ATE373718 T1 AT E373718T1 AT 00945107 T AT00945107 T AT 00945107T AT 00945107 T AT00945107 T AT 00945107T AT E373718 T1 ATE373718 T1 AT E373718T1
Authority
AT
Austria
Prior art keywords
aminopeptidase
polynucleotides
invention further
polypeptides
relates
Prior art date
Application number
AT00945107T
Other languages
English (en)
Inventor
Rosana Kapeller-Libermann
Mark Williamson
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Application granted granted Critical
Publication of ATE373718T1 publication Critical patent/ATE373718T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT00945107T 1999-06-30 2000-06-30 17867, eine menschliche aminopeptidase ATE373718T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/345,650 US6362324B1 (en) 1999-06-30 1999-06-30 17867 a novel human aminopeptidase

Publications (1)

Publication Number Publication Date
ATE373718T1 true ATE373718T1 (de) 2007-10-15

Family

ID=23355903

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00945107T ATE373718T1 (de) 1999-06-30 2000-06-30 17867, eine menschliche aminopeptidase

Country Status (8)

Country Link
US (4) US6362324B1 (de)
EP (1) EP1190071B1 (de)
JP (1) JP2003503049A (de)
AT (1) ATE373718T1 (de)
AU (1) AU5909600A (de)
DE (1) DE60036469T2 (de)
ES (1) ES2292449T3 (de)
WO (1) WO2001000811A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003243618A1 (en) * 2002-06-14 2003-12-31 Board Of Regents, The University Of Texas System Fiber cell globulization aminopeptidases and methods for treating or preventing cataracts
WO2004104575A2 (en) * 2003-05-23 2004-12-02 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with x-prolyl aminopeptidase 2 (xpnpep2)
ATE396158T1 (de) * 2003-12-22 2008-06-15 Mapei Spa Frühhochfeste superbetonverflüssiger
US7109015B2 (en) * 2004-03-29 2006-09-19 Academia Sinica Removal of N-terminal methionine from proteins by engineered methionine aminopeptidase
US7645220B2 (en) * 2005-11-08 2010-01-12 Anatasol, Llc Perineometer with wireless biofeedback
US8383799B2 (en) 2006-01-20 2013-02-26 Cell Signaling Technology, Inc. Translocation and mutant ROS kinase in human non-small cell lung carcinoma
JP5554925B2 (ja) * 2006-01-20 2014-07-23 セル・シグナリング・テクノロジー・インコーポレイテツド ヒト非小細胞肺癌における転座及び変異体ｒｏｓキナーゼ
GB0803076D0 (en) 2008-02-20 2008-03-26 Univ Ghent Mucosal Membrane Receptor and uses thereof
WO2022104279A1 (en) * 2020-11-16 2022-05-19 Arizona Board Of Regents On Behalf Of The University Of Arizona Vibrio toxin binding proteins in shrimp and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0464533B1 (de) 1990-06-28 1998-07-29 Hoechst Aktiengesellschaft Fusionsproteine mit immunglobulinanteilen, ihre Herstellung und Verwendung
US5968764A (en) * 1994-09-20 1999-10-19 Bayer Corporation Glucose transporter vesicle aminopeptidase
WO1997038114A1 (en) 1996-04-09 1997-10-16 Novartis Ag Puromycin-sensitive aminopeptidases
US5811535A (en) * 1996-08-09 1998-09-22 Smithkline Beecham Corporation Human cartilege gp39-like gene
WO1999011799A2 (en) 1997-09-02 1999-03-11 Medical College Of Georgia Research Institute, Inc. Human aminopeptidase p gene
EP1021538A1 (de) 1997-10-07 2000-07-26 Cadus Pharmaceutical Corporation Modifizierte g proteine-exprimierende hefezellen und ihre verwendungen

Also Published As

Publication number Publication date
WO2001000811A8 (en) 2003-10-23
WO2001000811A3 (en) 2001-03-22
US6362324B1 (en) 2002-03-26
JP2003503049A (ja) 2003-01-28
US20060105386A1 (en) 2006-05-18
DE60036469D1 (de) 2007-10-31
AU5909600A (en) 2001-01-31
EP1190071A2 (de) 2002-03-27
DE60036469T2 (de) 2008-06-19
EP1190071B1 (de) 2007-09-19
US20090004672A1 (en) 2009-01-01
US20020098177A1 (en) 2002-07-25
US7977059B2 (en) 2011-07-12
WO2001000811A2 (en) 2001-01-04
WO2001000811A9 (en) 2002-07-25
ES2292449T3 (es) 2008-03-16
US7034111B2 (en) 2006-04-25

Similar Documents

Publication Publication Date Title
ATE360077T1 (de) 22025, eine neue menschliche zyklische nukleotiden phosphodiesterase
WO2001057081A3 (en) Narc-1, subtilase-like homologs
EP0849361A3 (de) Neue Liganden des Neuropeptide Rezeptors HFGAN72
WO2001032891A3 (en) Human lipase
WO2002086076A3 (en) Polynucleotides and polypeptides associated with the nf-kb pathway
WO2002072751A3 (en) Polynucleotides encoding a metalloprotease, mp-1
DE60036469D1 (de) 17867, eine menschliche aminopeptidase
EA200400399A1 (ru) Способы лечения легочных заболеваний
WO2001036605A3 (en) 2786, a human aminopeptidase
MXPA03005436A (es) Polinucleotidos novedosos que codifican fosfastasas humanas.
WO2003048323A3 (en) Polynucleotides and polypeptides associated with the development of rheumatoid arthritis
WO2001023590A3 (en) 22196, a novel human aminopeptidase
WO2001064880A3 (en) Human dynamin 40322
DE602004029671D1 (de) (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicycloä3.2.0üheptan mit analgetischer wirksamkeit
ITTO20000674A0 (it) Composizioni a base di aminoacidi, atte al trattamento dell'insufficienza cardiaca.
WO2001023589A3 (en) 23431, a novel human ubiquitin protease
WO2001064858A3 (en) 25312, a human agmatinase-like homolog
DE69918446D1 (de) Polynucleotide and polypeptide basb033 aus neisseria meningitidis und ihre verwendungen
WO2001000787A3 (en) Methods of treatment using lig 72a and variants thereof
WO2001000812A3 (en) 22012, a novel human carboxypeptidase
ATE348889T1 (de) 27411, eine menschliche phosphatidyl- glycerinphosphate (pgp) synthase
WO1999030670A3 (en) Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
WO2001064887A3 (en) 32705, 23224, 27423, 32700, 32712, novel human g-proteins
MY146601A (en) Chemokine receptor antagonists and methods of use therefor
WO2001064873A3 (en) Human gtpase activator proteins

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties